These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30736835)

  • 21. Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.
    Warendorf JK; van der Star GM; Dooijes D; Notermans NC; Vrancken AFJE
    Neurol Sci; 2023 Oct; 44(10):3679-3685. PubMed ID: 37266816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
    Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
    Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS).
    Cruz MW; Pinto MV; Pinto LF; Gervais R; Dias M; Perez C; Mundayat R; Ong ML; Pedrosa RC; Foguel D
    Arq Neuropsiquiatr; 2019 Feb; 77(2):96-100. PubMed ID: 30810593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
    Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathological features of familial amyloid polyneuropathy].
    Koike H; Sobue G
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1134-7. PubMed ID: 22277509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis.
    Hsu HC; Liao MF; Hsu JL; Lee YL; Ro LS
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transthyretin familial amyloid polyneuropathy - three Hungarian cases with rare mutations (His88Arg and Phe33Leu)].
    Csillik A; Pozsonyi Z; Soós K; Balogh I; Bodó I; Arányi Z
    Ideggyogy Sz; 2016 Jul; 69(7-8):245-253. PubMed ID: 29465889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
    Ungerer MN; Hund E; Purrucker JC; Huber L; Kimmich C; Aus dem Siepen F; Hein S; Kristen AV; Hinderhofer K; Kollmer J; Schönland S; Hegenbart U; Weiler M
    Amyloid; 2021 Jun; 28(2):91-99. PubMed ID: 33283548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
    J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
    Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
    Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis.
    Zhen DB; Swiecicki PL; Zeldenrust SR; Dispenzieri A; Mauermann ML; Gertz MA
    Clin Genet; 2015 Oct; 88(4):396-400. PubMed ID: 25211232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy Clusters Are Located in Ancient Mining Districts: A Possible Geochemical Origin of the Disease.
    Roos PM; Wärmländer SKTS
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
    Andrés N; Poza JJ; Martí Massó JF
    Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
    Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
    Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
    Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
    Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
    Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V
    Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G
    J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
    Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
    Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.